Showing results (341-350 of 357) with videos related to
Sort By:
Pageof 36
European Archives of Psychiatry and Clinical Neuroscience|July 31, 1998
Distribution of the B33 CTG repeat polymorphism in a subtype of schizophreniaD Bengel, U Balling, G Stöber, et al.Journal of Medicinal Chemistry|October 19, 2001
Hydrophilic, pro-drug analogues of T138067 are efficacious in controlling tumor growth in vivo and show a decreased ability to cross the blood brain barrierS M Rubenstein, V Baichwal, H Beckmann, et al.American Journal of Medical Genetics|March 26, 1998
Adenosine A1 receptor and bipolar affective disorder: systematic screening of the gene and association studiesJ Deckert, M M Nöthen, M Albus, et al.Neuroreport|May 31, 1996
A null mutation allele in the CNTF gene and schizophrenic psychosesJ Thome, N Durany, A Harsányi, et al.American Journal of Medical Genetics|July 14, 2000
A European multicenter association study of HTR2A receptor polymorphism in bipolar affective disorderI Massat, D Souery, O Lipp, et al.Neuroscience Letters|October 29, 2002
Norepinephrine transporter gene (NET) variants in patients with panic disorderP G Sand, T Mori, C Godau, et al.Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Novel antineoplastic agents with efficacy against multidrug resistant tumor cellsJ C Medina, B Shan, H Beckmann, et al.Archives of Surgery (Chicago, Ill. : 1960)|June 22, 2011
Effect of incomplete parathyroidectomy preserving entire parathyroid glands on renal graft functionMark D Jäger, Stephan Kaaden, Nikos Emmanouilidis, et al.Psychiatric Genetics|April 28, 2001
Exonic variants of the GABA(B) receptor gene and panic disorderP G Sand, C Godau, P Riederer, et al.Proceedings of the National Academy of Sciences of the United States of America|May 13, 1999
Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumorsB Shan, J C Medina, E Santha, et al.Pageof 36